Orega Biotech
🏢 View company profile →5Patents
5Active
5Granted
47Portfolio score
Filing activity: Jun 11, 2013 → Jun 30, 2022
Most-cited patents
| Patent | Title | Area | Cited by | Status |
|---|---|---|---|---|
| US11578136B2 | Compositions and methods for treating cancer | Chemistry; Metallurgy | 1 | Active |
| US9676847B2 | IL-17 antagonist antibodies | Chemistry; Metallurgy | 0 | Active |
| US12202907B2 | Nucleic acids encoding and methods of producing proteins comprising antibody chains | Chemistry; Metallurgy | 0 | Active |
| US10351623B2 | Antagonists of IL-17 isoforms and their uses | Chemistry; Metallurgy | 0 | Active |
| US9834601B2 | Antagonists of IL-17 isoforms and their uses | Chemistry; Metallurgy | 0 | Active |
Source: USPTO / EPO open patent data. Counts and citation impact are objective bibliographic measures.